Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-25 4:18 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | INTEGRATED CORE STRATEGIES (US) LLC | 4,493,261 4.97% | 931,924 (+26.17%) | View |
| 2024-03-18 4:39 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | MILLENNIUM MANAGEMENT LLC | 4,262,021 4.7% | 4,262,021 (New Position) | View |
| 2024-02-14 4:47 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 5,283,982 5.97% | 971,851 (+22.54%) | View |
| 2024-02-14 08:24 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 7,635,000 8.5% | 635,000 (+9.07%) | View |
| 2024-02-13 5:09 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,954,233 11.12% | 642,472 (+6.90%) | View |
| 2024-02-08 10:14 am Purchase | 13G | MYRIAD GENETICS INC MYGN | WELLINGTON MANAGEMENT GROUP LLP | 7,219,706 8.07% | 432,483 (+6.37%) | View |
| 2024-01-24 1:20 pm Sale | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 4,700,631 5.25% | -319,792 (-6.37%) | View |
| 2024-01-23 4:31 pm Sale | 13G | MYRIAD GENETICS INC MYGN | INTEGRATED CORE STRATEGIES (US) LLC | 3,561,337 4% | -699,704 (-16.42%) | View |
| 2024-01-22 2:03 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 14,658,349 16.6% | 302,250 (+2.11%) | View |
| 2023-10-17 4:14 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | INTEGRATED CORE STRATEGIES (US) LLC | 4,261,041 5.2% | 4,261,041 (New Position) | View |
| 2023-03-01 4:10 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 4,312,131 5.31% | 4,312,131 (New Position) | View |
| 2023-02-14 08:46 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 7,000,000 8.64% | 2,300,000 (+48.94%) | View |
| 2023-02-09 11:27 am Purchase | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,311,761 11.49% | 162,240 (+1.77%) | View |
| 2023-02-06 2:53 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | WELLINGTON MANAGEMENT GROUP LLP | 6,787,223 8.38% | 2,461,448 (+56.90%) | View |
| 2023-01-31 09:19 am Purchase | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 5,020,423 6.2% | 610,020 (+13.83%) | View |
| 2023-01-23 3:52 pm Sale | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 14,356,099 17.7% | -328,688 (-2.24%) | View |
| 2023-01-09 5:09 pm Sale | 13G | MYRIAD GENETICS INC MYGN | EARNEST PARTNERS LLC | 3,304,456 4.1% | -3,011,909 (-47.68%) | View |
| 2022-05-12 4:06 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 4,700,000 5.85% | 1,950,000 (+70.91%) | View |
| 2022-02-14 09:39 am Sale | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 2,750,000 3.44% | -2,250,000 (-45.00%) | View |
| 2022-02-11 3:19 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 4,410,403 5.52% | 694,873 (+18.70%) | View |